Post-Approval Monitoring Requirements for Biotech Firms
Post-approval monitoring has become a central regulatory and commercial obligation for biotech firms operating in the United States. Following product approval, companies must generate ongoing evidence to confirm safety, effectiveness, and real-world performance. This phase is increasingly scrutinized by regulators, payers, and healthcare providers, particularly for advanced biologics, gene therapies, and precision medicines entering the … Read more